Zentalis Pharmaceuticals Llc (NASDAQ: ZNTL) — Healthcare · Share Price, Chart & Market Data
About: Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers in the United States. The company develops azenosertib, which is in a Phase 3 clinical trial for the treatment of ovarian cancer and other tumor types. It also develops ZN-c3-001, a phase 1 study that evaluated azenosertib monotherapy in solid tumors; and MAMMOTH (ZN-c3-006) is a Phase 1/2 clinical trial of azenosertib in patients with PARP-inhibitor resistant ovarian cancer. It has licensing agreements and strategic collaborations with Recurium IP Holdings, LLC. Zentalis Pharmaceuticals, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $3.98 (+2.31%)
ZNTLZentalis Pharmaceuticals Llc
Loading watchlist status…
Trade ZNTL now
Zentalis Pharmaceuticals Llc share price
ZNTL price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 9:09 am GMT+0
ZNTL price performance
-0.251%
5D
89.524%
1M
190.511%
YTD
180.282%
1Y
ZNTL price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NASDAQ rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 9:09 am GMT+0
ZNTL details
ZNTL Market Signals